Temporal Trajectory of Body Image Disturbance in Patients with Surgically Treated Head and Neck Cancer
Autor: | Judith M. Skoner, Evan M Graboyes, David M. Neskey, Eric J. Lentsch, Elizabeth G. Hill, Stacey Maurer, Joshua D. Hornig, Courtney H. Marsh, Terry A Day, Katherine R. Sterba |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_specialty Time Factors Body image disturbance Article 03 medical and health sciences 0302 clinical medicine Quality of life Survivorship curve Body Image Medicine Humans In patient Patient Reported Outcome Measures Prospective Studies 030223 otorhinolaryngology Aged business.industry Head and neck cancer Middle Aged Plastic Surgery Procedures medicine.disease Disfigurement Otorhinolaryngology Head and Neck Neoplasms 030220 oncology & carcinogenesis Cohort Trajectory Quality of Life Surgery Female Radiology business |
Zdroj: | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 162(3) |
ISSN: | 1097-6817 |
Popis: | OBJECTIVES. To characterize the temporal trajectory of body image disturbance (BID) in patients with surgically treated head and neck cancer (HNC). STUDY DESIGN. Prospective cohort study. SETTING. Academic medical center. SUBJECTS AND METHODS: Patients with HNC who were undergoing surgery completed the Body Image Scale (BIS), a validated patient-reported outcome measure of BID, pretreatment and 1, 3, 6, 9, and 12 months posttreatment. Changes in BIS scores (ΔBIS) relative to pretreatment (primary endpoint) were analyzed with a linear mixed model. Associations between demographics, clinical characteristics, psychosocial attributes, and persistently elevated BIS scores and increases in BIS scores ≥5 points relative to pretreatment (secondary endpoints) were analyzed through logistic regression. RESULTS. Of the 68 patients, most were male (n = 43), had oral cavity cancer (n = 37), and underwent microvascular reconstruction (n = 45). Relative to baseline, mean ΔBIS scores were elevated at 1 month postoperatively (2.9; 95% CI, 1.3–4.4) and 3 (3.2; 95% CI, 1.5–4.9) and 6 (1.8; 95% CI, 0.02–3.6) months posttreatment before returning to baseline at 9 months posttreatment (0.9; 95% CI, −0.8 to 2.5). Forty-three percent of patients (19 of 44) had persistently elevated BIS scores at 9 months posttreatment relative to baseline, and 51% (31 of 61) experienced an increase in BIS scores ≥5 relative to baseline. CONCLUSIONS. In this cohort of patients surgically treated for HNC, BID worsens posttreatment before returning to pretreatment (baseline) levels at 9 months posttreatment. However, 4 in 10 patients will experience a protracted course with persistent posttreatment body image concerns, and half will experience a significant increase in BIS scores relative to pretreatment levels. |
Databáze: | OpenAIRE |
Externí odkaz: |